Recruiting Amyloidosis Studies in Buffalo
About Amyloidosis Clinical Trials in Buffalo
Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.
There are currently 1 amyloidosis clinical trials recruiting participants in Buffalo, NEW%20YORK. These studies are seeking a combined 220 participants. Research is being sponsored by Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Amyloidosis Clinical Trials in Buffalo — FAQ
Are there amyloidosis clinical trials in Buffalo?
Yes, there are 1 amyloidosis clinical trials currently recruiting in Buffalo, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Buffalo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you about next steps.
Are clinical trials in Buffalo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buffalo studies also compensate for your time and travel.
What amyloidosis treatments are being tested?
The 1 active trials in Buffalo are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.
Data updated March 2, 2026 from ClinicalTrials.gov